Plasma 17-hydroxyprogesterone (17-OHP) concentrations in normal men averaged 0.094 µg/100 ml. Studies using suppressive doses of androgens and glucocorticoids showed that 90% of the 17-OHP originated from the Leydig cell. The 17-OHP production rate was 1.8 mg/24 hr. Plasma 17-OHP has a marked circadian variation, the 8 p.m. values being only 40% of the 8 a.m. values. Plasma luteinizing hormone measured in the same samples did not vary.
INTRODUCTION
Progesterone' and 17-hydroxyprogesterone are intermediates in the biosynthesis of adrenal cortical and gonadal hormones. They are secreted in relaReceived for publication 31 October 1968 and in revised form 9 January 1969. ' The following abbreviations and trivial names are used: progesterone = pregn-4-ene-3,20,dione; 17-hydroxyprogesterone (17-OHP) = 17a-hydroxypregn-4-ene-3,20-dione; cortisol = 11j8,17a,21-trihydroxypregn-4-ene-3,20-dione; fluoxymesterone = 9a-fluoro-17a-methyl-11,,17,8-dihydroxyandrost-4-en-3-one; dexamethasone = 9a-fluoro-16a-methyl-1 1p,17a, 21 -trihydroxypregn-1,4-diene-3,20-dione; testosterone = 17,8- hydroxyandrost-4-en-3-one; androstenedione = androst-4-ene-3,20-dione; dehydroepiandrosterone = 3p-hydroxyandrost-5-en-17-one; 17-hydroxypregnenolone = 3j8,17a-dihydroxypregn-5-en-20-one; 17-hydroxypregnenolone sulfate = 3-ylsulfate-17a-hydroxypregn-5-en-20-one; dehydroepiandrosterone sulfate = 3-yl-sulfate-androst-5-en-20-one; pregnanetriol = 53-pregnane-3a,17a,20a-triol; pregnanediol = 58-pregnane3a,20a-diol; LH = luteinizing hormone or interstitial cell stimulating hormone; FSH = follicle-stimulating hormone; ACTH = adrenocorticotrophic hormone.
tively small amounts by normal subjects but may have high secretion rates when there are distal enzymatic blocks, such as in congenital adrenal hyperplasia (CAH). To study in greater detail the function of the steroidproducing glands, we have examined the plasma concentration and sources of plasma progesterone and 17-OHP under varying conditions. We shall report here the utility of these measurements for investigating normal Leydig cell function and adrenal cortical function in CAH.
METHODS
Subjects. The normal men and women ranged in age from 20 to 47 yr. When circadian variation was examined, plasma samples were obtained after the subjects had been in the recumbent position for at least 1 hr. Five patients, ranging from 5 to 16 yr of age, with the simple virilizing form of CAH were studied.
Plasma steroids. Cortisol was measured fluorimetrically
(1). Plasma 17-OHP was measured by a protein-binding technique (2) that has a coefficient of variation of ±6%o at plasma levels as low as 0.020 ug/100 ml. Plasma progesterone also measured by a protein-binding method of similar precision (3) was modified so that the free steroid fraction was separated from that fraction bound to protein by adsorption to Florisil (2) . Plasma luteinizing hormone (LH) levels in the studies of diurnal variation were estimated by radioimmunoassay (4) .a All LH samples were measured in a single assay: the intra-assay coefficient of variation is ±8%. Metabolic clearance rates. The metabolic clearance rates of 17-OHP and progesterone were measured by the constant infusion technique. All studies were begun between 8 and 9 a.m. with the subjects recumbent and fasting. The radioactive steroids were infused and their levels measured as described previously (5) . There was no consistent trend of the level of plasma radioactivity in either steroid and the average deviation from the mean was less than 5% for 17-OHP and 7%o for progesterone. In one man with localized osteogenic sarcoma, 17-OHP-3H was infused for 10 hr to look for possible diurnal variations in the metabolic clearance rate.
'We wish to thank Dr. Griff T. Ross, Endocrinology
Branch, NCI, for the measurement of the plasma LH levels.
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The Journal of Clinical Investigation Volume 48 1969 RESULTS Progesterone and 17-OHP in normal adults. The mean plasma concentration of 17-OHP in normal men was 0.094 p.g/100 ml, a level significantly higher than that of women in the follicular phase of the menstrual cycle (0.042 pg/100 ml) (Fig. 1) . Although the mean 17-OHP level of ovariectomized women was lower than that of women in the follicular phase, the difference was not significant.
Progesterone levels were significantly higher in women than in men (0.041 vs. 0.019 pg/100 ml) (Fig.   1 ). The mean plasma progesterone level was reduced by ovariectomy but the difference was not significant. The intraindividual variation of progesterone and 17-OHP was examined by measuring plasma levels at 8 a.m. daily for 6 days in three normal men. The variations from the mean were 52, 38, and 35% for progesterone, and 27, 33, and 18% for 17-OHP.
Of some interest was the finding that the mean 17-OHP level in random plasma samples obtained from women in the luteal phase of the menstrual cycle was four to five times that of women in the follicular phase (Fig. 2) .
The implications of this will be discussed elsewhere but it is necessary to be aware of this large change in plasma levels when performing horizontal studies in women.
Since 17-OHP was higher in men than in women who did not have a functioning corpus luteum, it was likely that 17-OHP was secreted by the testis. When a synthetic androgen, fluoxymesterone, was given to normal men at a dose of 40 mg daily for 3 days there was a 90% decrease in plasma 17-OHP (Fig. 3) . Dexamethasone in a dosage of 4 mg daily for 4 days, however, did not lower plasma 17-OHP although it produced the anticipated decrease in plasma cortisol concentrations (Fig.  3) . When 4000 IU of human chorionic gonadotrophin (HCG) was given for 4 days to three normal men, there was a 2-to 3-fold increase in plasma 17-OHP (Fig. 4) . Because of the marked circadian variation in plasma 17-OHP levels (vide infra), this effect was more apparent when samples obtained in the late afternoon were compared ( of the hypothalamic-pituitary Leydig cell system, we measured plasma 17-OHP and LH concentrations every 6 hr in the nine normal men for a period of 2 days. The results of these studies are presented in Fig. 5 production rate averaged 1.8 mg/24 hr. In CAH, production rates of 55 and 113 mg/24 hr were noted. No correction factor for plasma 17-OHP was used in these two studies. DISCUSSION There are many data suggesting that a small fraction of each intermediate in steroid biosynthesis "leaks" into the effluent vein and thereby becomes a secretory product. Thus, each intermediate in cortisol biosynthesis has been detected in the adrenal cortical venous effluent and many of the intermediates in testosterone and estrogen biosynthesis have been identified in the venous effluent from the testis and ovary respectively. Nevertheless, the production rate of 17-OHP is an unusually large fraction of the testosterone production rate. The mean testosterone production rate of normal men in this laboratory is 7 mg/24 hr and the 17-OHP production rate was 1.8 mg/ 24 hr or 25% of the tesosterone production rate.
The reasons for this large production rate of 17-OHP by the testis are obscure. In the testis, 17-OHP is metabolized further only by the lyase catalyzing the conversion of 17-OHP to androstenedione. By contrast, in the adrenal cortex 17-OHP is hydroxylated and utilized for cortisol biosynthesis as well, and the lyase may, therefore, be of lesser importance in the further metabolism of 17-OHP. As we have shown, little 17-OHP is normally secreted by the adrenal cortex.
The results of our studies in normal men are clearly consistent with the origin of 17-OHP from the testis. This does not prove testicular secretion of 17-OHP since these data would also be consistent with secretion of a precursor and subsequent peripheral conversion to 17-OHP. This explanation would require a high secretion 17 -OHP were also 6%, then the production rate of 17-hydroxypregnenolone would have to be 3 mg to account for as much as 10% of the 17-OHP production rate. The possible role of 17-hydroxypregnenolone sulfate in 17-OHP production may be minimized since dehydroepiandrosterone sulfate is a poor precursor of androstenedione peripherally (7) . It is therefore probable that 17-OHP is secreted rather than produced peripherally from a testicular precursor. Previous studies of urinary pregnanetriol (8) have demonstrated mean differences in its excretion between men and women as we would predict but the ranges overlapped. This may be due in part to random sampling throughout the menstrual cycle and to methodologic problems in the analysis of urinary pregnanetriol. The finding that 17-OHP is derived from the Leydig cell was anticipated by the report that HCG increased urinary pregnanetriol excretion in men (9) .
The circadian rhythm of plasma 17-OHP is of greater magnitude than that reported for plasma testosterone.
In those studies, the 7 to 10 p.m. testosterone concentrations were 63% (10), 61% (11), 73% (12) , and 69% (13) of the 7 to 9 a.m. values. The reason for this difference is unknown. Since the plasma samples in this study were obtained after at least an hour's rest, the metabolic clearance rates could not have varied as a result of altered hepatic blood flow. Since there was no consistent change of the metabolic clearance rate from 9:00 a.m. to 7:00 p.m., it is unlikely that the profound swings in plasma 17-OHP are due to comparable changes in clearance rate; rather they must reflect the secretory activity of the Leydig cell.
The question of the existence of a circadian rhythm of plasma LH has been examined by many investigators and there is substantial agreement that there is no (4, (13) (14) (15) 
